This inventor holds 3 USPTO granted patents. Top assignee: The Jackson Laboratory. Active years: 1985-1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Otter Creek, ME (US) (1985)
- Bar Harbor, ME (US) (1997)
Company Filing History:
Years Active: 1985-1997
Title: Edward H. Leiter: A Pioneering Inventor in Clinical Therapeutics
Introduction: Edward H. Leiter, hailing from Bar Harbor, Maine, is an accomplished inventor with a remarkable record of three patents. His innovative work primarily focuses on therapeutic methods addressing clinical disorders associated with genetic mutations. As a dedicated researcher, Leiter is affiliated with The Jackson Laboratory, a prominent institution known for its contributions to genetics and biomedical research.
Latest Patents: One of Leiter's significant patents involves a therapeutic method for treating clinical disorders linked to mutations in the carboxypeptidase E gene. This innovative approach introduces molecules with carboxypeptidase activity into the plasma of patients. Notable examples of these molecules include carboxypeptidase H, carboxypeptidase M, carboxypeptidase N, carboxypeptidase U, and carboxypeptidase B. The patent also details methods for identifying individuals who may benefit from the therapy, incorporating the isolation of DNA encoding carboxypeptidase E followed by comparison with wild-type sequences. Additionally, oligonucleotide probes are offered for diagnosing related clinical disorders, such as obesity, impaired glucose tolerance, and diabetes, thereby advancing the understanding and treatment of these conditions.
Career Highlights: Edward H. Leiter's career at The Jackson Laboratory has been marked by his commitment to research and innovation in the field of clinical therapeutics. His contributions not only enhance scientific knowledge but also provide potential pathways for developing effective treatments for patients suffering from genetic disorders.
Collaborations: Throughout his career, Leiter has had the privilege of collaborating with esteemed colleagues such as Douglas L. Coleman and Norman Applezweig. These collaborations have enriched his research endeavors and facilitated advancements in the understanding of carboxypeptidase E and its implications in various clinical disorders.
Conclusion: Edward H. Leiter stands out as a visionary inventor whose work significantly impacts the field of genetics and medicine. Through his patents and collaborations, Leiter continues to pave the way for innovative therapeutic methods that address complex clinical challenges. His ongoing dedication to research at The Jackson Laboratory exemplifies the spirit of innovation that drives advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
